From concept to in vivo testing: Microcontainers for oral drug delivery

J Control Release. 2017 Dec 28:268:343-351. doi: 10.1016/j.jconrel.2017.10.013. Epub 2017 Oct 18.

Abstract

This work explores the potential of polymeric micrometer sized devices (microcontainers) as oral drug delivery systems (DDS). Arrays of detachable microcontainers (D-MCs) were fabricated on a sacrificial layer to improve the handling and facilitate the collection of individual D-MCs. A model drug, ketoprofen, was loaded into the microcontainers using supercritical CO2 impregnation, followed by deposition of an enteric coating to protect the drug from the harsh gastric environment and to provide a fast release in the intestine. In vitro, in vivo and ex vivo studies were performed to assess the viability of the D-MCs as oral DDS. D-MCs improved the relative oral bioavailability by 180% within 4h, and increased the absorption rate by 2.4 times compared to the control. This work represents a significant step forward in the translation of these devices from laboratory to clinic.

Keywords: Enteric coating; Microtechnology; Oral drug delivery; Supercritical impregnation.

MeSH terms

  • Administration, Oral
  • Animals
  • Capsules
  • Dicarboxylic Acids / administration & dosage
  • Dicarboxylic Acids / chemistry
  • Drug Delivery Systems*
  • Drug Liberation
  • Gastric Mucosa / metabolism
  • Jejunum / metabolism
  • Ketoprofen / administration & dosage
  • Ketoprofen / blood
  • Ketoprofen / chemistry
  • Ketoprofen / pharmacokinetics
  • Male
  • Polymethacrylic Acids / administration & dosage
  • Polymethacrylic Acids / chemistry
  • Povidone / administration & dosage
  • Povidone / chemistry
  • Rats, Sprague-Dawley

Substances

  • Capsules
  • Dicarboxylic Acids
  • Polymethacrylic Acids
  • methylmethacrylate-methacrylic acid copolymer
  • dibutyl sebacate
  • Ketoprofen
  • Povidone